Filing metadata

Accession number
0001209191-18-021317
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Mar 22, 2018
Reporting period
Mar 21, 2018
Description
Insider transaction

Explore SEC Filings Hub